SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-074355
Filing Date
2018-12-21
Accepted
2018-12-21 12:53:09
Documents
1
Period of Report
2018-12-21

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 29195
  Complete submission text file 0001104659-18-074355.txt   30537
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Issuer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ENDOCYTE, INC. 3000 KENT AVENUE, SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Parker Katherine (Reporting) CIK: 0001633299 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35050 | Film No.: 181248598